Millennium Management
BCAB icon

Millennium Management’s BioAtla BCAB Stock Holding History

Millennium Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,404
Closed -$579K – 6360
2022
Q4 		$579K Buy
+1,404
New +$582K ﹤0.01% 4629

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management's BCAB Position: Q1 2026 in Review

Millennium Management increased its BioAtla (BCAB) stake by 262% in Q1 2026, buying an estimated $467K and bringing the position to 55,133 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #4830.

Millennium Management first reported a position in BCAB in Q4 2020 and has held it in 20 quarters since. The position peaked at $11.1M in Q4 2020. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Millennium Management held 55,133 shares of BioAtla worth $444K as of Q1 2026.
  • Millennium Management bought 39,885 BioAtla shares in Q1 2026, an estimated $467K.
  • BioAtla made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4830 holding.
  • Millennium Management first reported a position in BioAtla in Q4 2020 and has held it in 20 quarters since.
  • Millennium Management's BioAtla position peaked at $11.1M in Q4 2020.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.